Physician profile
Ankit Mathur
NPI 1699302737
$2,119.64
in general payments reported to CMS, 2019-2025
16 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Sleep Medicine (Family Medicine) provider received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $577 · 2022: $174 · 2023: $288 · 2024: $90.00 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.95 |
| Education | $135.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $285.98 | 2021-2023 | Xarelto |
| Avadel Cns Pharmaceuticals, LLC | $263.16 | 2025 | Lumryz |
| Astrazeneca Pharmaceuticals Lp | $249.39 | 2021-2023 | Farxiga |
| Harmony Biosciences LLC | $215.45 | 2025 | |
| Inspire Medical Systems, INC. | $194.97 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $179.86 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $171.57 | 2021-2022 | |
| Lilly USA, LLC | $151.40 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $124.62 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.17 | 2021 | |
| Pfizer INC. | $53.26 | 2022-2023 | |
| Novo Nordisk INC | $40.73 | 2022 | |
| 3b Medical, INC. | $33.68 | 2025 | Luna |
| Fisher & Paykel Healthcare INC | $25.47 | 2025 | Fisher & Paykel Healthcare |
| Idorsia Pharmaceuticals US INC | $24.96 | 2023 | Quviviq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $16.97 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.